Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab

PURPOSE: The objectives of this study were to evaluate and compare treatment patterns and infusion-related health care resource expenditures for rheumatoid arthritis (RA) patients initiating golimumab for intravenous use (GLM-IV) and infliximab (IFX) therapy and to assess cost implications from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Lorie A, Malangone-Monaco, Elisabetta, Varker, Helen, Stetsovsky, Diana, Kubacki, Maureen, DeHoratius, Raphael J, Kafka, Shelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338107/
https://www.ncbi.nlm.nih.gov/pubmed/30679916
http://dx.doi.org/10.2147/CEOR.S185547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338107/
https://www.ncbi.nlm.nih.gov/pubmed/30679916
http://dx.doi.org/10.2147/CEOR.S185547

Ejemplares similares